betamethasone 0.5 MG/ML Topical Cream [Del-Beta]

RxCUI: 213541
RxNorm name: betamethasone 0.5 MG/ML Topical Cream [Del-Beta]
Display name: DEL-BETA (Topical)
Full name: betamethasone 0.5 MG/ML Topical Cream [Del-Beta]
Term type: SBD
Status: Active
Strength: 0.05%
Dose form: Cream
Route: Topical
Updated: 2026-11-14 08:24:44

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 042005
Active start: 042005
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
betamethasone dipropionate	0.5 MG / 1 ML	betamethasone	betamethasone

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Cream	316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
betamethasone	1514

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Del-Beta 0.05 % Topical Cream	1	NAMES
RxNorm Name	betamethasone 0.5 MG/ML Topical Cream [Del-Beta]	1	NAMES
RxNorm Synonym	3 linked values Del-Beta 0.05 % Topical Cream Del-Beta 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Topical Cream Del-Beta 0.5 MG/ML Topical Cream	3	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	213541	1	CODES
MMSL_CODE	BD706	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00316017645	rxnav_ndcs	yes
00316017615	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	C05AA	Corticosteroids	ATC1-4		betamethasone
ATC	S03BA	Corticosteroids	ATC1-4		betamethasone
ATC	S02BA	Corticosteroids	ATC1-4		betamethasone
ATC	R01AD	Corticosteroids	ATC1-4		betamethasone
ATC	A07EA	Corticosteroids acting locally	ATC1-4		betamethasone
ATC	S01BA	Corticosteroids, plain	ATC1-4		betamethasone
ATC	D07AC	Corticosteroids, potent (group III)	ATC1-4		betamethasone
ATC	D07XC	Corticosteroids, potent, other combinations	ATC1-4		betamethasone
ATC	S01CB	Corticosteroids/antiinfectives/mydriatics in combination	ATC1-4		betamethasone
ATC	R03BA	Glucocorticoids	ATC1-4		betamethasone
ATC	H02AB	Glucocorticoids	ATC1-4		betamethasone
FDASPL	N0000175576	Corticosteroid	EPC	has_epc	betamethasone
FDASPL	N0000175450	Corticosteroid Hormone Receptor Agonists	MOA	has_moa	betamethasone
MEDRT	D001623	Betamethasone	CHEM	has_ingredient	betamethasone
MEDRT	D003876	Dermatitis, Atopic	DISEASE	may_treat	betamethasone
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	betamethasone
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	betamethasone
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	betamethasone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	betamethasone
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	betamethasone
MEDRT	D007249	Inflammation	DISEASE	may_treat	betamethasone
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	betamethasone
MEDRT	D009181	Mycoses	DISEASE	ci_with	betamethasone
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	betamethasone
MEDRT	D011565	Psoriasis	DISEASE	may_treat	betamethasone
MEDRT	D016553	Purpura, Thrombocytopenic, Idiopathic	DISEASE	ci_with	betamethasone
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	betamethasone
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	betamethasone
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	betamethasone
MEDRT	N0000008297	Antipruritic Activity	PE	has_pe	betamethasone
MEDRT	N0000008327	Carbohydrate Metabolism Alteration	PE	has_pe	betamethasone
MEDRT	N0000009928	Decreased Cellular Migration	PE	has_pe	betamethasone
MEDRT	N0000008645	Decreased Glucocorticoid Secretion	PE	has_pe	betamethasone
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	betamethasone
MEDRT	N0000008700	Decreased Lysosomal Function	PE	has_pe	betamethasone
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	betamethasone
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	betamethasone
MEDRT	N0000009004	Decreased Thromboxane Activity	PE	has_pe	betamethasone
MEDRT	N0000009739	Lipid Metabolism Alteration	PE	has_pe	betamethasone

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Del-Beta	rxnav_allrelated
DF	DF	Topical Cream	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	betamethasone	rxnav_allrelated
SBD	SBD	betamethasone 0.5 MG/ML Topical Cream [Del-Beta]	rxnav_allrelated
SBDC	SBDC	betamethasone 0.5 MG/ML [Del-Beta]	rxnav_allrelated
SBDF	SBDF	betamethasone Topical Cream [Del-Beta]	rxnav_allrelated
SBDG	SBDG	Del-Beta Topical Product	rxnav_allrelated
SCD	SCD	betamethasone 0.5 MG/ML Topical Cream	rxnav_allrelated
SCDC	SCDC	betamethasone 0.5 MG/ML	rxnav_allrelated
SCDF	SCDF	betamethasone Topical Cream	rxnav_allrelated
SCDG	SCDG	betamethasone Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.5 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	Del-Beta 0.05 % Topical Cream
SOURCES	Source	Gold Standard Alchemy